HELP S.A.

Ukraine

All drugs from this manufacturer

  • CARNELIUS

    The drug is used for the emergency and long-term treatment of patients with congenital metabolic disorders that lead to carnitine deficiency. It is also prescribed for the prevention and treatment of carnitine deficiency in patients with end-stage renal disease undergoing dialysis.

    Dosage form: solution for injection

    Active substance Dosage
    levocarnitine 200 mg/ml

    ATC: A16AA01

  • The drug is used for iron deficiency if the patient cannot take iron in tablet form (due to intolerance or ineffectiveness) or has gastrointestinal diseases that are exacerbated by oral preparations.

    Dosage form: solution for injection

    Active substance Dosage
    iron iii hydroxide sucrose complex 20 mg/ml

    ATC: B03AC

  • The drug is used to treat active pulmonary tuberculosis and extrapulmonary forms of tuberculosis (specifically renal involvement) if other primary drugs have not yielded results. It is also used for acute urinary tract infections caused by certain bacteria if standard treatment has been ineffective.

    Dosage form: capsules

    Active substance Dosage
    cycloserine 250 mg

    ATC: J04AB01

  • It is used for carnitine deficiency in adults and children (including newborns), as well as in patients undergoing hemodialysis.

    Dosage form: solution for injection

    Active substance Dosage
    levocarnitine 200 mg/ml

    ATC: A16AA01

  • The drug is used for short-term symptomatic treatment of acute attacks of rheumatoid arthritis and ankylosing spondylitis in cases where other routes of administration cannot be used.

    Dosage form: solution for injection

    Active substance Dosage
    meloxicam 15 mg/1.5 mL

    ATC: M01AC06

  • The drug is intended for short-term symptomatic treatment of acute attacks of rheumatoid arthritis and ankylosing spondylitis in adults when other routes of administration cannot be used.

    Dosage form: solution for injection

    Active substance Dosage
    meloxicam 15 mg/1.5 mL

    ATC: M01AC06

  • The drug is used for short-term symptomatic relief during acute attacks of rheumatoid arthritis and ankylosing spondylitis in adults, when other routes of administration cannot be used.

    Dosage form: solution for injection

    Active substance Dosage
    meloxicam 15 mg/1.5 mL

    ATC: M01AC06

  • The drug is intended for short-term symptomatic treatment of an acute attack of rheumatoid arthritis and ankylosing spondylitis in adults, when other routes of administration cannot be used.

    Dosage form: solution for injection

    Active substance Dosage
    meloxicam 15 mg/1.5 mL

    ATC: M01AC06

  • The drug is intended for short-term relief in adults during acute attacks of rheumatoid arthritis and ankylosing spondylitis when other routes of administration cannot be used.

    Dosage form: solution for injection

    Active substance Dosage
    meloxicam 15 mg/1.5 mL

    ATC: M01AC06

  • The drug is used for short-term symptomatic treatment of acute rheumatoid arthritis and ankylosing spondylitis in cases where other routes of administration cannot be used.

    Dosage form: solution for injection

    Active substance Dosage
    meloxicam 15 mg/1.5 mL

    ATC: M01AC06

  • The drug is used to prevent or relieve nausea and vomiting caused by chemotherapy, radiation therapy, or following surgical procedures.

    Dosage form: solution for injection

    Active substance Dosage
    ondansetron 2 mg/ml

    ATC: A04AA01

  • The drug is used for short-term symptomatic treatment of acute rheumatoid arthritis and ankylosing spondylitis in cases where other routes of administration cannot be used.

    Dosage form: solution for injection

    Active substance Dosage
    meloxicam 15 mg/1.5 mL

    ATC: M01AC06

  • The drug is used for the treatment of primary (congenital) and secondary carnitine deficiency, as well as for cardiomyopathy.

    Dosage form: solution, oral

    Active substance Dosage
    levocarnitine 100 mg/ml

    ATC: A16AA01

  • The drug is used to treat carnitine deficiency (primary or secondary) in adults and children, including newborns. It is also prescribed to patients undergoing hemodialysis if they experience muscle weakness, seizures, cardiomyopathy, or energy deficiency.

    Dosage form: solution for injection

    Active substance Dosage
    levocarnitine 200 mg/ml

    ATC: A16AA01